Best Practice & Research Clinical Rheumatology
Volume 22, Issue 6 , Pages 1075-1091 , December 2008

Role of imaging in vasculitis and connective tissue diseases

References 

  1. Salvarani C, Brown RD, Calamia KT, et al. Primary central nervous system vasculitis: analysis of 101 patients. Annals of Neurology. 2007;62:442–451
  2. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. The New England Journal of Medicine. 2002;347:261–271
  3. Pipitone N, Versari A, Salvarani C. Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. Rheumatology (Oxford). 2008;47:403–408
  4. Blockmans D, De Ceuninck L, Vanderschueren S, et al. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis and Rheumatism. 2006;55:131–137
  5. Bongartz T, Matteson EL. Large-vessel involvement in giant cell arteritis. Current Opinion in Rheumatology. 2006;18:10–17
  6. Schmidt WA, Kraft HE, Vorpahl K, et al. Color duplex ultrasonography in the diagnosis of temporal arteritis. The New England Journal of Medicine. 1997;337:1336–1342
  7. Salvarani C, Silingardi M, Ghirarduzzi A, et al. Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis?. Annals of Internal Medicine. 2002;137:232–238
  8. Karassa FB, Matsagas MI, Schmidt WA, Ioannidis JP. Meta-analysis: test performance of ultrasonography for giant-cell arteritis. Annals of Internal Medicine. 2005;142:359–369
  9. Salvarani C, Ghinoi A, Macchioni P, et al. Is magnetic resonance imaging useful for the diagnosis of giant cell arteritis?. Arthritis and Rheumatism. 2006;54:S488
  10. Bley TA, Wieben O, Uhl M, et al. High-resolution MRI in giant cell arteritis: imaging of the wall of the superficial temporal artery. AJR. American Journal of Roentgenology. 2005;184:283–287
  11. Bley TA, Weiben O, Uhl M, et al. Assessment of the cranial involvement pattern of giant cell arteritis with 3T magnetic resonance imaging. Arthritis and Rheumatism. 2005;52:2470–2477
  12. Schmidt WA, Both M, Reinhold-Keller E. Imaging in vasculitis, Zeitschrift für Rheumatologie. 2006;65:652–661
  13. Bley TA, Wieben O, Uhl M, et al. Integrated head-thoracic vascular MRI at 3 T: assessment of cranial, cervical and thoracic involvement of giant cell arteritis. Magma. 2005;18:193–200
  14. Kissin EY, Merkel PA. Diagnostic imaging in Takayasu arteritis. Current Opinion in Rheumatology. 2004;16:31–37
  15. Meller J, Strutz F, Siefker U, et al. Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. European Journal of Nuclear Medicine and Molecular Imaging. 2003;30:730–736
  16. Bley TA, Brink I, Reinhard M. Imaging procedures for giant cell arteritis (Horton's disease), Ophthalmologe. 2006;103:308–316
  17. Brodmann M, Lipp RW, Passath A, et al. The role of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology (Oxford). 2004;43:241–242
  18. Karahaliou M, Vaiopoulos G, Papaspyrou S, et al. Colour duplex sonography of temporal arteries before decision for biopsy: a prospective study in 55 patients with suspected giant cell arteritis. Arthritis Research and Therapy. 2006;8:R116
  19. Schmidt WA, Natusch A, Moller DE, et al. Involvement of peripheral arteries in giant cell arteritis: a color Doppler sonography study. Clinical and Experimental Rheumatology. 2002;20:309–318
  20. Bley TA, Wieben O, Leupold J, Uhl M. Images in cardiovascular medicine. Magnetic resonance imaging findings. Circulation. 2005;111:e260
  21. Vanoli M, Daina E, Salvarani C, et al. Takayasu's arteritis: a study of 104 Italian patients. Arthritis and Rheumatism. 2005;53:100–107
  22. Maeda H, Handa N, Matsumoto M, et al. Carotid lesions detected by B-mode ultrasonography in Takayasu's arteritis: ‘macaroni sign’ as an indicator of the disease. Ultrasound in Medicine and Biology. 1991;17:695–701
  23. Yamada I, Nakagawa T, Himeno Y, et al. Takayasu arteritis: diagnosis with breath-hold contrast-enhanced three-dimensional MR angiography. Journal of Magnetic Resonance Imaging. 2000;11:481–487
  24. Yamada I, Nakagawa T, Himeno Y, et al. Takayasu arteritis: evaluation of the thoracic aorta with CT angiography. Radiology. 1998;209:103–109
  25. Meller J, Grabbe E, Becker W, Vosshenrich R. Value of F-18 FDG hybrid camera PET and MRI in early Takayasu aortitis. European Radiology. 2003;13:400–405
  26. Webb M, Chambers A, Al Nahhas A, et al. The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis. European Journal of Nuclear Medicine and Molecular Imaging. 2004;31:627–634
  27. Buckley A, Southwood T, Culham G, et al. The role of ultrasound in evaluation of Takayasu's arteritis. The Journal of Rheumatology. 1991;18:1073–1080
  28. Tso E, Flamm SD, White RD, et al. Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis and Rheumatism. 2002;46:1634–1642
  29. Wenger M, Calamia KT, Salvarani C, et al. Do we need 18F-FDG-positron emission tomography as a functional imaging technique for diagnosing large vessel vasculitis?. Clinical and Experimental Rheumatology. 2003;21:S1–S2
  30. Borhani HA, Pourmand R, Nikseresht AR. Neuro-Behcet disease. A review. Neurologist. 2005;11:80–89
  31. Pipitone N, Boiardi L, Olivieri I, et al. Clinical manifestations of Behcet's disease in 137 Italian patients: results of a multicenter study. Clinical and Experimental Rheumatology. 2004;22:S46–S51
  32. Pipitone N, Olivieri I, Padula A, et al. Infliximab for the treatment of neuro-Behcet's disease: a case series and review of the literature. Arthritis and Rheumatism. 2008;59:285–290
  33. Erkan F. Pulmonary involvement in Behcet disease. Current Opinion in Pulmonary Medicine. 1999;5:314–318
  34. Tunaci M, Ozkorkmaz B, Tunaci A, et al. CT findings of pulmonary artery aneurysms during treatment for Behcet's disease. AJR. American Journal of Roentgenology. 1999;172:729–733
  35. Duzgun N, Ates A, Aydintug OT, et al. Characteristics of vascular involvement in Behcet's disease. Scandinavian Journal of Rheumatology. 2006;35:65–68
  36. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on rheumatic fever, Endocarditis and Kawasaki disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110:2747–2771
  37. Hiraishi S, Misawa H, Takeda N, et al. Transthoracic ultrasonic visualisation of coronary aneurysm, stenosis, and occlusion in Kawasaki disease. Heart. 2000;83:400–405
  38. Stanson AW, Friese JL, Johnson CM, et al. Polyarteritis nodosa: spectrum of angiographic findings. Radiographics. 2001;21:151–159
  39. Hekali P, Kajander H, Pajari R, et al. Diagnostic significance of angiographically observed visceral aneurysms with regard to polyarteritis nodosa. Acta Radiologica. 1991;32:143–148
  40. Cordier JF, Valeyre D, Guillevin L, et al. Pulmonary Wegener's granulomatosis. A clinical and imaging study of 77 cases. Chest. 1990;97:906–912
  41. Frazier AA, Rosado-de-Christenson ML, Galvin JR, Fleming MV. Pulmonary angiitis and granulomatosis: radiologic-pathologic correlation. Radiographics. 1998;18:687–710
  42. Lohrmann C, Uhl M, Kotter E, et al. Pulmonary manifestations of Wegener granulomatosis: CT findings in 57 patients and a review of the literature. European Journal of Radiology. 2005;53:471–477
  43. Lee KS, Kim TS, Fujimoto K, et al. Thoracic manifestation of Wegener's granulomatosis: CT findings in 30 patients. European Radiology. 2003;13:43–51
  44. Muller NL, Staples CA, Miller RR, et al. Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation. Radiology. 1987;165:731–734
  45. Choi YH, Im JG, Han BK, et al. Thoracic manifestation of Churg-Strauss syndrome: radiologic and clinical findings. Chest. 2000;117:117–124
  46. Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore). 1984;63:65–81
  47. Worthy SA, Muller NL, Hansell DM, Flower CD. Churg-Strauss syndrome: the spectrum of pulmonary CT findings in 17 patients. AJR. American Journal of Roentgenology. 1998;170:297–300
  48. Guillevin L, Durand-Gasselin B, Cevallos R, et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis and Rheumatism. 1999;42:421–430
  49. Seo JB, Im JG, Chung JW, et al. Pulmonary vasculitis: the spectrum of radiological findings. British Journal of Radiology. 2000;73:1224–1231
  50. Lauque D, Cadranel J, Lazor R, et al. Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Groupe d'Etudes et de Recherche sur les Maladies ‘Orphelines’ Pulmonaires (GERM'O'P). Medicine (Baltimore). 2000;79:222–233
  51. Ando Y, Okada F, Matsumoto S, Mori H. Thoracic manifestation of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-related disease. CT findings in 51 patients. Journal of Computer Assisted Tomography. 2004;28:710–716
  52. Ha HK, Lee SH, Rha SE, et al. Radiologic features of vasculitis involving the gastrointestinal tract. Radiographics. 2000;20:779–794
  53. Ahualli J. The target sign: bowel wall. Radiology. 2005;234:549–550
  54. Launay D, Remy-Jardin M, Michon-Pasturel U, et al. High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis. The Journal of Rheumatology. 2006;33:1789–1801
  55. Desai SR, Veeraraghavan S, Hansell DM, et al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology. 2004;232:560–567
  56. Pope JE, Lee P, Baron M, et al. Prevalence of elevated pulmonary arterial pressures measured by echocardiography in a multicenter study of patients with systemic sclerosis. The Journal of Rheumatology. 2005;32:1273–1278
  57. Hachulla E, Gressin V, Guillevin L, et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis and Rheumatism. 2005;52:3792–3800
  58. McGoon M, Gutterman D, Steen V, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest. 2004;126:14S–34S
  59. Kovacs B, Lafferty TL, Brent LH, DeHoratius RJ. Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Annals of the Rheumatic Diseases. 2000;59:120–124
  60. Brey RL. Neuropsychiatric lupus: clinical and imaging aspects. Bulletin of the NYU Hospital for Joint Diseases. 2007;65:194–199
  61. Sibbitt WL, Sibbitt RR, Brooks WM. Neuroimaging in neuropsychiatric systemic lupus erythematosus. Arthritis and Rheumatism. 1999;42:2026–2038
  62. Abreu MR, Jakosky A, Folgerini M, et al. Neuropsychiatric systemic lupus erythematosus: correlation of brain MR imaging, CT, and SPECT. Clinical Imaging. 2005;29:215–221
  63. Peterson PL, Axford JS, Isenberg D. Imaging in CNS lupus. Best Practice and Research. Clinical Rheumatology. 2005;19:727–739
  64. Theodoridou A, Settas L. Demyelination in rheumatic diseases. Journal of Neurology, Neurosurgery, and Psychiatry. 2006;77:290–295
  65. Appenzeller S, Bonilha L, Rio PA, et al. Longitudinal analysis of gray and white matter loss in patients with systemic lupus erythematosus. NeuroImage. 2007;34:694–701
  66. Rayner CF, Grubnic S. Pulmonary manifestations of systemic autoimmune disease. Best Practice and Research. Clinical Rheumatology. 2004;18:381–410
  67. Ooi GC, Ngan H, Peh WC, et al. Systemic lupus erythematosus patients with respiratory symptoms: the value of HRCT. Clinical Radiology. 1997;52:775–781
  68. Dubois EL. Pulmonary manifestations of lupus erythematosus systemicus. In:  Wallace DJ,  Hahn BH editor. Dubois' lupus erythematosus. Philadelphia: Lippincott Williams and Wilkins; 2006;p. 678
  69. Costabel U, Dubois RM, Egan JJ. Diffuse parenchymal lung disease. Basel: Karger; 2007;
  70. Cheema GS, Quismorio FP. Interstitial lung disease in systemic lupus erythematosus. Current Opinion in Pulmonary Medicine. 2000;6:424–429
  71. Chisholm DM, Mason DK. Labial salivary gland biopsy in Sjogren's disease. Journal of Clinical Pathology. 1968;21:656–660
  72. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American–European Consensus Group. Annals of the Rheumatic Diseases. 2002;61:554–558
  73. Aung W, Yamada I, Umehara I, et al. Sjogren's syndrome: comparison of assessments with quantitative salivary gland scintigraphy and contrast sialography. Journal of Nuclear Medicine. 2000;41:257–262
  74. Daniels TE, Benn DK. Is sialography effective in diagnosing the salivary component of Sjogren's syndrome?. Advances in Dental Research. 1996;10:25–28
  75. Henriksen AM, Nossent HC. Quantitative salivary gland scintigraphy can distinguish patients with primary Sjogren's syndrome during the evaluation of sicca symptoms. Clinical Rheumatology. 2007;26:1837–1841
  76. Nishiyama S, Miyawaki S, Yoshinaga Y. A study to standardize quantitative evaluation of parotid gland scintigraphy in patients with Sjogren's syndrome. The Journal of Rheumatology. 2006;33:2470–2474
  77. Wernicke D, Hess H, Gromnica-Ihle E, et al. Ultrasonography of salivary glands – a highly specific imaging procedure for diagnosis of Sjogren's syndrome. The Journal of Rheumatology. 2008;35:285–293
  78. Takagi Y, Sumi M, Sumi T, et al. MR microscopy of the parotid glands in patients with Sjogren's syndrome: quantitative MR diagnostic criteria. AJNR. American Journal of Neuroradiology. 2005;26:1207–1214
  79. Morgen K, McFarland HF, Pillemer SR. Central nervous system disease in primary Sjogren's syndrome: the role of magnetic resonance imaging. Seminars in Arthritis and Rheumatism. 2004;34:623–630
  80. Escudero D, Latorre P, Codina M, et al. Central nervous system disease in Sjogren's syndrome. Annales de médecine interne. 1995;146:239–242
  81. Coates T, Slavotinek JP, Rischmueller M, et al. Cerebral white matter lesions in primary Sjogren's syndrome: a controlled study. The Journal of Rheumatology. 1999;26:1301–1305
  82. Parambil JG, Myers JL, Lindell RM, et al. Interstitial lung disease in primary Sjogren syndrome. Chest. 2006;130:1489–1495
  83. Scott DL, Kingsley GH. Use of imaging to assess patients with muscle disease. Current Opinion in Rheumatology. 2004;16:678–683
  84. Sultan SM. Clinical assessment in adult onset idiopathic inflammatory myopathy. Current Opinion in Rheumatology. 2004;16:668–672
  85. Fraser DD, Frank JA, Dalakas M, et al. Magnetic resonance imaging in the idiopathic inflammatory myopathies. The Journal of Rheumatology. 1991;18:1693–1700
  86. Dion E, Cherin P, Payan C, et al. Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis. The Journal of Rheumatology. 2002;29:1897–1906
  87. Phillips BA, Cala LA, Thickbroom GW, et al. Patterns of muscle involvement in inclusion body myositis: clinical and magnetic resonance imaging study. Muscle and Nerve. 2001;24:1526–1534
  88. Fathi M, Dastmalchi M, Rasmussen E, et al. Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Annals of the Rheumatic Diseases. 2004;63:297–301
  89. Douglas WW, Tazelaar HD, Hartman TE, et al. Polymyositis-dermatomyositis-associated interstitial lung disease. American Journal of Respiratory and Critical Care Medicine. 2001;164:1182–1185
  90. Oshiro Y, Murayama S, Moromizato H, et al. CT findings of pulmonary hemorrhage: spectrum of disease. Radiologist. 2003;10:249–260

PII: S1521-6942(08)00112-5

doi: 10.1016/j.berh.2008.09.015

Best Practice & Research Clinical Rheumatology
Volume 22, Issue 6 , Pages 1075-1091 , December 2008

Article Tools

* Image Usage & Resolution